Summary Keywords Alzheimers disease, clinical trial, cognitive dysfunction, GLP-1 receptor agonist, neuroinflammation, neuroprotection, semaglutide, vascular dementia Citation Alhowail AH, Al Mouslem AK, Almatrafi MA and Aldubayan MA (2026) Semaglutide in cognitive dysfunction: neuroprotective potential, clinical trial limitations, and a prevention-focused framework
Bottom Line: Glutathione injections are more than just a trendtheyre a science-backed way to enhance detoxification, boost energy, strengthen immunity, and even support youthful skin
When performed by trained medical professionals, IV therapy is generally safe
These three steps, done consistently, address the core mechanisms of GLP-1-related lean mass loss
doi: 10.1080/03602532.2017.1293683 24 CeccarelliSPaneraNMinaMGnaniDDe StefanisCCrudeleAet al
Tirzepatide was reported in only one study, and individual drugs could not be analyzed separately